Announced
Completed
Financials
Tags
diagnostics products
Private
Friendly
Cross Border
Single Bidder
Majority
Private Equity
Medical Supplies
United Kingdom
Completed
Acquisition
testing inspection and certification
Synopsis
Novo Holdings, a global life sciences investor, completed the acquisition of BBI Group, a supplier of products and services to the global diagnostics and life sciences industries, from Exponent, a private equity firm, for c.£400m ($564m). "We see tremendous opportunities for both organic and inorganic growth for the company. Novo Holdings is looking forward to contributing its considerable industry expertise and extensive network in supporting the talented team at BBI," Johan Hueffer, Novo Holdings Senior Partner.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.